Driehaus Capital Management’s Jade Biosciences JBIO Stock Holding History

Driehaus Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.93M	Sell	635,498 -251,681	-28%	-$3.64M	0.07%	273
2025 Q4	$13.7M	Sell	887,179 -368,619	-29%	-$4.32M	0.09%	254
2025 Q3	$10.8M	Hold	1,255,798	–	–	0.08%	269
2025 Q2	$12.5M	Buy	+1,255,798	New	+$42.7M	0.1%	232
2024 Q2	–	Sell	-22,714	Closed	-$23.5M	–	370
2024 Q1	$23.5M	Sell	22,714 -7,521	-25%	-$5.74M	0.23%	124
2023 Q4	$23.9M	Sell	30,235 -3,697	-11%	-$1.88M	0.29%	111
2023 Q3	$16.1M	Sell	33,932 -185	-0.5%	-$100K	0.21%	156
2023 Q2	$20.5M	Buy	+34,117	New	+$21.8M	0.26%	123
2022 Q4	–	Sell	-1,339	Closed	-$777K	–	351
2022 Q3	$777K	Buy	+1,339	New	+$894K	0.01%	310

Other funds holding JBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return